1. Home
  2. FPI vs PLRX Comparison

FPI vs PLRX Comparison

Compare FPI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.69

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

93.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
PLRX
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
93.3M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
FPI
PLRX
Price
$9.69
$1.23
Analyst Decision
Hold
Analyst Count
0
11
Target Price
N/A
$3.79
AVG Volume (30 Days)
534.1K
1.9M
Earning Date
02-18-2026
11-06-2025
Dividend Yield
2.48%
N/A
EPS Growth
296.76
N/A
EPS
1.27
N/A
Revenue
$52,990,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$1.10
52 Week High
$12.87
$13.71

Technical Indicators

Market Signals
Indicator
FPI
PLRX
Relative Strength Index (RSI) 40.86 39.68
Support Level $9.62 $1.20
Resistance Level $9.73 $1.27
Average True Range (ATR) 0.16 0.06
MACD -0.05 0.01
Stochastic Oscillator 7.14 22.58

Price Performance

Historical Comparison
FPI
PLRX

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: